About Perrigo
Perrigo is a company based in Allegan (United States) founded in 1887. The company has 8,380 employees as of December 31, 2024. Perrigo has completed 15 acquisitions, including Agisgroup, CanAm Care and Diba. Perrigo offers products and services including Ibuprofen Tablets, Infant Formula, Acetaminophen, and Minoxidil Topical Solution. Perrigo operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Allegan, United States
- Employees 8380 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Perrigo Company Plc
-
Annual Revenue
$4.37 B (USD)-6.04as on Dec 31, 2024
-
Net Profit
-$171.8 M (USD)-1252.76as on Dec 31, 2024
-
EBITDA
$644 M (USD)0.36as on Dec 31, 2024
-
Latest Funding Round
$600 M (USD), Post-IPO
Sep 11, 2016
-
Investors
Not available
-
Employee Count
8380
as on Dec 31, 2024
-
Investments & Acquisitions
Agisgroup
& 14 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Perrigo
Perrigo is a publicly listed company on the NYSE with ticker symbol PRGO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Perrigo
Perrigo offers a comprehensive portfolio of products and services, including Ibuprofen Tablets, Infant Formula, Acetaminophen, and Minoxidil Topical Solution.
Tablets for reducing pain and fever in consumers
Formula for infant feeding and nutrition support
Medication for pain and fever management
Treatment for hair regrowth in men
People of Perrigo
Unlock access to complete
Unlock access to complete
Software Development Team
141 people
Leadership Team
90 people
Sales and Marketing
74 people
Senior Team
49 people
Operations Team
32 people
Human Resources and Administration
23 people
Global Team
23 people
Finance and Accounting
21 people
Unlock access to complete
Funding Insights of Perrigo
Investments & Acquisitions by Perrigo
Perrigo has strategically engaged in corporate development activities, having acquired 15 companies. Notable acquisitions include Agisgroup, CanAm Care and Diba.
Investment portfolio details for Perrigo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gelcaps are exported from Mexico by the company since 2018.
|
Locked | Locked | 2018 | Locked | |
|
Agisgroup was founded in 2010 with domain agisgroup.com.
|
Locked | Locked | 2010 | Locked | |
|
Manufacturer of pharmaceutical eye drop product
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Perrigo
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Perrigo
Detailed financials for Perrigo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Perrigo Comparisons
Peer comparison for Perrigo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Perrigo
Perrigo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Detailed competitors of Perrigo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Perrigo
Complete news archive for Perrigo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Perrigo
Perrigo was founded in 1887 and raised its 1st funding round 129 years after it was founded.
Perrigo is headquartered in Allegan, United States. It is registered at Allegan, Michigan, United States.
Patrick Lockwood Taylor is the current CEO of Perrigo.
As of Dec 31, 2024, the latest employee count at Perrigo is 8,380.
Annual revenue of Perrigo is $4.37B as on Dec 31, 2024.
Perrigo was founded in 1887 and is headquartered in Allegan, United States. Over-the-counter and generic prescription pharmaceuticals, infant formulas, nutritional products, dietary supplements, and active pharmaceutical ingredients are produced and distributed by the company within the healthcare sector. Operations focus on consumer goods, with royalties earned from Tysabri, a treatment for multiple sclerosis and Crohns disease.
Perrigo's top competitors include Merck, Roivant Sciences and Amgen.
Perrigo offers Ibuprofen Tablets, Infant Formula, Acetaminophen, and Minoxidil Topical Solution.
Yes, Perrigo is publicly traded on NYSE under the ticker symbol PRGO.
Perrigo has made 15 acquisitions, including Agisgroup, CanAm Care, and Diba.
The ticker symbol of Perrigo is PRGO on NYSE.